PTGES and lung adenocarcinoma: Recently, Deng et al. reported that a prostaglandin E Synthase inhibitor (Cay10526) suppressed tumor malignant progression in a spontaneous lung adenocarcinoma model (Wang et al, 2020); however, its clinical benefits require further investigation.